Skip to main content
Log in

Extraosseous plasmacytoma in the nasal cavity after rituximab therapy against pulmonary MALT lymphoma

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Wöhrer S, Troch M, Streubel B, Hoffmann M, Müllauer L, Chott A, Raderer M (2007) Pathology and clinical course of MALT lymphoma with plasmacytic differentiation. Ann Oncol 18(12):2020–2024

    Article  PubMed  Google Scholar 

  2. Woehrer S, Streubel B, Chott A, Hoffmann M, Raderer M (2005) Transformation of MALT lymphoma to pure plasma cell histology following treatment with the anti-CD20 antibody rituximab. Leuk Lymphoma 46(11):1645–1649

    Article  CAS  PubMed  Google Scholar 

  3. Klein N, Elis A, Radnay J, Zemer R, Klein A, Lishner M (2009) Transformation of MALT lymphoma to pure plasma cell histology: possible association with anti-CD20 antibody treatment. Isr Med Assoc J 11(11):703–704

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mineo Kurokawa.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nakamura, F., Nakamura, F., Ikemura, M. et al. Extraosseous plasmacytoma in the nasal cavity after rituximab therapy against pulmonary MALT lymphoma. Ann Hematol 95, 1733–1735 (2016). https://doi.org/10.1007/s00277-016-2751-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-016-2751-6

Keywords

Navigation